Medpace Holdings: It Might Be Time To Buy In

I stumbled upon Medpace (NASDAQ: MEDP ) once in 2022, but didn't research it properly. Since then, I have never taken another glimpse at them. Now, two and a half years later, with the share price dropping by 35% andHi! I'm a passionate investor who has been researching publically traded companies for over 6 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term. While I have a slight bias toward technology companies, I maintain a broad perspective ...